If you have obstructive sleep apnoea, you’re definitely not alone. According to the latest scientific research1, more than 936 million people around the world are affected.
This remarkable figure, which was published in the world’s leading respiratory health journal, is nearly 10 times greater than the World Health Organisation’s 2007 estimate of over 100 million. It’s led to new calls for physicians to step up their efforts to screen, diagnose and prescribe treatment for this manageable disorder.
“More than 85 percent of [obstructive] sleep apnoea patients are undiagnosed,” explains Carlos M. Nunez, M.D., a study co-author and Resmed’s chief medical officer. “This raises their risk of workplace and road accidents, and can contribute to other significant health problems, such as hypertension, cardiovascular disease, or even poor glucose control for diabetic patients. We know the risks and now we know the size of the problem. Addressing it starts with screening patients we know to be high-risk.”